Launched Methotex (Methotrexate For Injection)

Launched Methotrexate in 2019 by the brand name Methotex 500mg/20ml, 1gm/40ml strength strength

Approved indications of Methotex

• Treatment of gestational choriocarcinoma, Chorioadenoma destruens and hydatidiform mole.
• Used alone or in combination with other anticancer agents in the treatment of breast cancer, epidermoid cancers of the head and neck, advanced mycosis fungoides (Cutaneous T cell lymphoma) and lung cancer.